1-(2,4-DIFLUOROPHENYL)CYCLOPROPANE-1-METHANAMINE, 95%, 250mg

N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarboxamide, 98%, 50mg

Connecteurs, GL 14, droit, 10 pièce(s)

4-Bromo-2-fluoro-5-methylbenzonitrile, 95.0%, 250mg

Ethyl-2,2-difluoro-2-(3-fluoro-4-methoxyphenyl)acetate, 95.0%, 1g

3-Bromo-N-phenylbenzamide, 95.0%, 5g

O-(4-Methoxy-benzyl)-hydroxylamine hydrochloride, 95.0%, 5g

tert-Butyl 3-(piperazin-1-yl)azetidine-1-carboxylate, 97%, 500mg

5-Hydroxy-1-tetralone, 98.0%, 1g

3,5-Bis(dimethylamino)benzamide, 250mg

(6-(Methoxycarbonyl)pyridin-3-yl)boronic acid, 95.0%, 1g

4-Bromo-3-nitrobenzoic Acid>98.0%(GC)(T)5g

4,6-Dichloro-2-(2-pyridinyl)pyrimidine, 95.0%, 250mg